We identified around 362,000 mutations in 18,919 genes in OCI-LY3, including PAX5, CD79B, CARD11, PIM1, mTOR, and BCL2, genes frequently mutated in DLBCL patients (Supplementary Table S1). This evidence concerns the gene CD8B and diffuse large B-cell lymphoma.